Clinical Strategy Lead
About the job
- A medical degree (MD or DO) is required.
- At least 3 years of post-training professional experience, including at least 2 years in client-facing roles such as consulting, customer success, implementation, or strategy.
- Prior experience working at early-stage startups or high-growth business units at health technology companies.
- A successful track record managing complex deployments and executive stakeholders in clinical environments.
- Hands-on experience engaging clinical and executive stakeholders at client organizations to shape product positioning in the market.
- Ability to build trust across technical and non-technical stakeholders and present data-driven insights compellingly.
- Ability to bring MD-level clinical credibility to the product and deepen the company's clinical expertise as offerings become more medically sophisticated.
- Must be based in New York City and willing to work in a hybrid environment, with approximately three days per week in the office.
- Serve as the external voice of Thesis's AI platform, helping customers understand its capabilities and clinical value.
- Lead consultative sales cycles with provider organizations, uncovering priorities and shaping solutions to serve customer needs.
- Build and nurture relationships with C-suite executives, service-line leaders, and clinical and IT stakeholders to foster trust, remove roadblocks, and champion adoption.
- Drive post-go-live success and expansion by orchestrating stakeholders to deliver on time, measuring outcomes, and upselling additional use cases.
- Feed customer insights back into the product by working with engineering and clinical teams to prioritize features and new use cases.
- Own product scope for new partnerships and partner with sales to translate client needs into defined, flexible product configurations.
- Work with customers throughout the partnership journey, from initial conversations through post-go-live; support sales and deployment discussions through solution design, partnership strategy, custom content creation, and discussions with senior customer leadership.
- Guide clinical product development by providing market and clinical perspectives.
About the company
Trovo Health provides AI-powered virtual assistants for medical practices that help clinicians and staff with routine tasks and patient care. The assistants are trained on specialty-specific models and workflows and plug into existing clinical processes without causing disruption. They handle activities such as patient communication, scheduling, triage, and documentation, guided by a multidisciplinary care team. The goal is to improve patient outcomes and operational efficiency by offering specialty-tailored, integrated AI support.
Company Size
N/A
Company Stage
Series A
Total Funding
$60M
Headquarters
New York City, New York
Founded
N/A
Get referred to Trovo Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- Thesis raised $45 million on March 25, 2026, bringing total funding to $60 million.
- Thesis is expanding from physician groups into health systems and payer care teams.
- Unio Health Partners deployed multiple Thesis agents on May 26, 2026, across California specialties.
What critics are saying
- EHR vendors bundle similar workflow automation, compressing Thesis margins by 2027.
- If Cottage Health and Unio stall, Thesis lacks a proven hospital-scale moat.
- A 2026 care-team breach or HIPAA investigation freezes enterprise sales immediately.
What makes Trovo Health unique
- Thesis combines AI agents with expert clinicians, not software-only chatbots.
- Cottage Health became Thesis's first health-system partner on August 5, 2026.
- Partnerships span US Heart & Vascular, Essen Health Care, Springfield Clinic, and Allied Digestive Health.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Unlimited Paid Time Off
Flexible Work Hours
Hybrid Work Options
Company Equity
Parental Leave
Company News
Trovo Health announced today that it is launching with a $15 million fundraise led by Oak HC/FT. Trovo uses an AI-powered platform backed by a multidisciplin...
Thesis Care, an AI-powered care team platform, has partnered with Unio Health Partners to deploy AI care team agents across Unio's specialty practices in California. Unio, the state's largest multi-specialty physician services platform, serves over 500,000 patients annually across 52 locations with 165 physicians. The partnership will deploy Thesis agents across workflows including care gap closure, patient engagement and prior authorisations. Thesis combines AI agents with expert clinicians to complete complex clinical work within existing systems, requiring no additional training for staff. Founded in 2024, Thesis is backed by Oak HC/FT, CRV and Black Opal Ventures. Unio provides urology, gastroenterology and radiation oncology care across California.
Trovo Health rebrands as Thesis Care, scores $45M and more funding news. AI revenue cycle management platform Adonis raises $40 million and Blossom Health, a telehealth platform for psychiatry, garners $20 million. By Jessica Hagen | March 27, 2026 | 12:51 PM Thesis Care, formerly Trovo Health, has secured $45 million in Series A funding in a round led by Oak HC/FT, bringing its total funding to $60 million. CRV also participated in the round, alongside Black Opal Ventures and other angel investors. Thesis offers AI agents within healthcare to assist with clinical operations and care management. The company will use the funds for commercial expansion, to enhance its technology platform and to expand its care team agents. "2025 was a defining year for Thesis as we moved from design partnerships into a clear commercial trajectory and growing customer base," Dr. Niren Gandra, CEO and cofounder of Thesis Care, said in a statement. "We've proven that we can extend clinical capacity and allow our customers to do more for patients at a scale that has historically been impossible. Now, we're ready to bring that to every healthcare organization that needs it." Adonis, an AI-enabled revenue cycle management platform, has raised $40 million in Series C funding, bringing its total raise to more than $95 million. Quadrille Capital led the round, with participation from existing investors General Catalyst and Bling Capital. The New York-based company offers an AI orchestration platform that monitors and detects revenue cycle issues by analyzing claims, denials and payer behavior. Adonis plans to use the funds to expand its presence with health systems and grow its workforce in New York. It will also accelerate product innovation across its intelligence, AI agents and orchestration platform. "This funding signals that investors are backing solutions that address the structural problems holding RCM teams back, including RCM workforce shortages, denials, and underpayments," Akash Magoon, cofounder and CEO of Adonis, said in a statement. "Our mission has always been to restore sanity to RCM, and this investment allows us to accelerate the technology RCM teams need to solve these challenges autonomously and at scale." Blossom Health, a telehealth platform for psychiatry, announced it raised $20 million in Series A and seed funding. Headline led the Series A round, with participation from new investors Operator Partners and Correlation Ventures and existing investors Village Global and TA Ventures. Several angel investors were involved in the round as well, including the founders of General Catalyst, Flatiron Health, Sword Health, Fay, Elemy, Zip, Blank Street, Assured, Bridge, Birches Health and Enzo Health. Mathias Schilling, cofounder and managing partner of Headline, joined Blossom Health's board of directors. The company helps individuals seeking mental health support connect with a psychiatrist covered by in-network insurance. The New York-based company will drive to contract with national and regional health insurance payers, expand its state coverage, invest in research and development to advance its AI and onboard more providers.
Thesis Care, formerly Trovo Health, has raised $45 million in a Series A round led by Oak HC/FT, with participation from CRV and Black Opal Ventures, bringing total funding to $60 million. The company combines AI agents with expert clinicians to handle complex clinical operations and care management workflows for healthcare organisations. Founded in 2024 by Niren Gandra and Aditya Pandyaram, Thesis's platform uses AI to deliver personalised patient engagement and complete workflow actions whilst integrating human clinical experts when needed. The system requires no additional training for staff and maintains existing workflows. The company's partnerships span thousands of providers, including US Heart & Vascular, Essen Health Care and Allied Digestive Health. The funding will support commercial expansion, platform development and broadening its suite of care team agents.
Trovo Health announced today that it is launching with a $15 million fundraise led by Oak HC/FT. Trovo uses an AI-powered platform backed by a multidi